This report evaluates the use, cost, and insurance impact of menopause-related treatments—especially prescription drugs—within Maryland’s healthcare system. It’s designed to inform policy decisions about coverage and potential mandates.

This mandate study uses Maryland's All-Payer Claims Database (APCD) to estimate the fiscal impact of requiring Medicaid and commercial insurers to cover aesthetic and restorative care for domestic violence survivors, finding that the mandate would result in modest premium increases across all market segments while highlighting significant data gaps — including the inability to identify DV-related claims — that underscore the need for improved tracking of DV/IPV injuries in administrative data.

This study quantifies a major shift in locus of VA critical care, a likely outcome of expanded non-VA health insurance coverage that was previously called out, but the study was not designed to address the many issues raised by outsourcing so much ICU care, including questions about the coordination and continuity of post-ICU care for these patients with high-acuity conditions. The study adds to concerns about VA’s ability to oversee the quality of community care and gaps in the integration of VA-delivered and VA-purchased care.

Patient-centered medical homes in Maryland’s multipayer demonstration disrupted the pattern of recurrently high expenditure among the costliest patients and improved continuity of care.

This study examines changes in healthcare expenditure and utilization in the individual and small group markets following the implementation of new insurance provisions from the ACA. The analysis relies on 2013 and 2014 data from Maryland’s Medical Care Database (MCDB).